Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PharmaCyte Biotech, Inc.
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
May 21, 2024
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
November 15, 2023
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
FEMY
PMCB
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
October 31, 2023
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces Final Results of Tender Offer
June 15, 2023
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
May 11, 2023
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan
February 02, 2023
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital
August 15, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation
July 28, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study
July 21, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study
July 19, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022
July 11, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells
July 05, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Issues Follow-Up Response to Iroquois Capital’s Second Letter on June 9 and Reiterates Commitment to Increasing Shareholder Value
June 15, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Attend 2022 BIO International Convention in San Diego
June 13, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Implement $10-Million Share Repurchase Program
June 02, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites
May 23, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes
April 27, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces More Positive Tests Results for Its Pancreatic Cancer Clinical Trial Product Candidate to Satisfy FDA Requirements
April 19, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Accelerate Preparations for Start of Pancreatic Cancer Clinical Trial
April 13, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Appoints Dr. Matthias Löhr to Board of Directors
April 05, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Successfully Completes 24-Month Stability Study of Its Clinical Trial Product Candidate
March 22, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights
March 16, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Announces Genetic Stability of Cytochrome P450 Gene and Site of Integration
February 22, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA
February 14, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference
January 06, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells
January 04, 2022
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study
December 28, 2021
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights
December 15, 2021
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
December 08, 2021
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
November 30, 2021
From
PharmaCyte Biotech, Inc.
Via
Business Wire
Tickers
PMCB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit